AR015279A1 - Proceso para la sintesis de inhibidores de cox-2 y compuestos intermediarios - Google Patents
Proceso para la sintesis de inhibidores de cox-2 y compuestos intermediariosInfo
- Publication number
- AR015279A1 AR015279A1 ARP990101884A ARP990101884A AR015279A1 AR 015279 A1 AR015279 A1 AR 015279A1 AR P990101884 A ARP990101884 A AR P990101884A AR P990101884 A ARP990101884 A AR P990101884A AR 015279 A1 AR015279 A1 AR 015279A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- formula
- aryl
- cox
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/30—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having nitrogen atoms of imino groups quaternised
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un proceso para la síntesis de inhibidores de COX-2 de la formula (I), en donde: 0-2 grupos R están presentes; cada R, R y R independientementerepresentan alquilo C1-10, arilo C6-10, aralquilo, halo, -S(O)mH, -S(O)malquiloC1-6, -S(O)marilo, nitro,am ino, alquilC1-6amino, di-alquilC1-6amino, -S(O)mNH2,-S(O)mNHalquiloC1-6, -S(O)mNHC(O)CF3 y ciano; los grupos alquilo y arilo, y las porciones alquilo y arilo de aralquilo, -S(O)malquiloC1-6, -S(O)marilo,alquilC1-6amino, di-alquilC1-6amino yS(O)mNHal quiloC1-6 son opcionalmente sustituidas con 1-3 grupos seleccionados entre alquilo C1-4, arilo, halo, hidroxilo,-S(O)mH, -S(O)malquiloC1-6, -CN, alcoxi C1-6, amino, alquilC1-6amino, di-alquilC1-6amino, -S(O)mNH2, -S(O)mNHalquiloC1-6,-S(O)mNHC(O)CF3 y ariloxi; Y es C oN; y m es 0, 1 o 2; caracterizado porque comprende hacer reaccionar un compuesto de formula (II) en donde R2 a R5 representan cada uno independientementealquilo C1-6, arilo o aralquilo, y X- representa un contraionadecuado, con un compuesto de la formula (III) en donde R, R e Y son como se definenanteriormente, en presencia de una base, para producir un compuesto de formula (I) y compuestos de formula (II).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8288898P | 1998-04-24 | 1998-04-24 | |
| US8566898P | 1998-05-15 | 1998-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015279A1 true AR015279A1 (es) | 2001-04-18 |
Family
ID=26767964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101884A AR015279A1 (es) | 1998-04-24 | 1999-04-23 | Proceso para la sintesis de inhibidores de cox-2 y compuestos intermediarios |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6040319A (es) |
| EP (1) | EP1071745B1 (es) |
| JP (2) | JP3325264B2 (es) |
| KR (1) | KR100414998B1 (es) |
| CN (1) | CN1178658C (es) |
| AR (1) | AR015279A1 (es) |
| AT (1) | ATE272613T1 (es) |
| AU (1) | AU759469B2 (es) |
| BR (2) | BR9909844B1 (es) |
| CA (1) | CA2329193C (es) |
| CZ (1) | CZ292515B6 (es) |
| DE (1) | DE69919151T2 (es) |
| DK (1) | DK1071745T3 (es) |
| EA (1) | EA002975B1 (es) |
| ES (1) | ES2226378T3 (es) |
| HK (1) | HK1031399A1 (es) |
| HR (1) | HRP20000722B1 (es) |
| HU (1) | HU227627B1 (es) |
| IL (2) | IL139127A0 (es) |
| NZ (1) | NZ507597A (es) |
| PL (1) | PL193248B1 (es) |
| PT (1) | PT1071745E (es) |
| RS (1) | RS49945B (es) |
| SI (1) | SI1071745T1 (es) |
| SK (1) | SK284805B6 (es) |
| TW (1) | TW474934B (es) |
| UA (1) | UA57143C2 (es) |
| WO (1) | WO1999055830A2 (es) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861419A (en) | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| KR100446324B1 (ko) | 1999-01-14 | 2004-08-30 | 론자 아게 | 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법 |
| PT1394149E (pt) * | 1999-01-14 | 2005-05-31 | Lonza Ag | Processo para a producao de 1-(6-metilpiridin-3-il)-2-[4-(metilsulfonil)fenil]etanona |
| JP2001115963A (ja) | 1999-10-13 | 2001-04-27 | Daikin Ind Ltd | 圧縮機 |
| CA2391650C (en) | 1999-11-29 | 2011-01-25 | Merck & Co., Inc. | Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl |
| US6858631B1 (en) | 1999-11-29 | 2005-02-22 | Merck & Co., Inc. | Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl |
| ES2236007T3 (es) * | 1999-12-08 | 2005-07-16 | Pharmacia Corporation | Composiciones de inhibidor de ciclooxigenasa-2 ue tiene un efecto terapeutico rapido. |
| JP2001261653A (ja) * | 2000-03-17 | 2001-09-26 | Sankio Chemical Co Ltd | ピリジン誘導体の合成法 |
| US6521642B2 (en) | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
| US6800647B2 (en) | 2000-05-26 | 2004-10-05 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis |
| US20020128267A1 (en) * | 2000-07-13 | 2002-09-12 | Rebanta Bandyopadhyay | Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| US7695736B2 (en) | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
| JP2005503346A (ja) * | 2001-05-04 | 2005-02-03 | メルク エンド カムパニー インコーポレーテッド | 片頭痛を治療するための方法及び組成物 |
| UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
| JP4700916B2 (ja) * | 2004-02-02 | 2011-06-15 | 富士フイルムファインケミカルズ株式会社 | ピリジン誘導体の製造方法 |
| US7271383B2 (en) * | 2004-08-11 | 2007-09-18 | Lexmark International, Inc. | Scanning system with feedback for a MEMS oscillating scanner |
| US20080096927A1 (en) | 2004-08-24 | 2008-04-24 | Simon Thomas J | Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events |
| WO2008091530A2 (en) * | 2007-01-19 | 2008-07-31 | Mallinckrodt Inc. | Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| ES2562981T3 (es) | 2009-02-27 | 2016-03-09 | Cadila Healthcare Limited | Un procedimiento para la preparación de Etoricoxib |
| EP2582690B1 (en) | 2010-06-16 | 2018-07-25 | Glenmark Generics Limited | Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates |
| UA114594C2 (uk) | 2010-11-15 | 2017-07-10 | Вірдев Інтермедіейтс Пвт. Лтд. | Спосіб одержання селективного інгібітора циклооксигенази-2 |
| ITMI20110362A1 (it) * | 2011-03-09 | 2012-09-10 | F I S Fabbrica Italiana Sint P A | Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
| WO2012163839A1 (en) | 2011-05-27 | 2012-12-06 | Farma Grs, D.O.O. | A process for the preparation of polymorphic form i of etoricoxib |
| ITMI20111455A1 (it) | 2011-07-29 | 2013-01-30 | Italiana Sint Spa | Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib. |
| CN103204803A (zh) | 2012-01-13 | 2013-07-17 | 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 | 用于合成依托考昔的方法 |
| ITMI20120394A1 (it) | 2012-03-14 | 2013-09-15 | Zach System Spa | Processo di sintesi di un chetosolfone derivato |
| EP2831045A2 (en) | 2012-03-30 | 2015-02-04 | Mylan Laboratories, Limited | An improved process for the preparation of etoricoxib |
| GR1007973B (el) * | 2012-06-26 | 2013-09-12 | Φαρματεν Αβεε, | Νεα ν-οξοιμινο παραγωγα ως ενδιαμεσα μιας βελτιωμενης μεθοδου παρασκευης 2,3-διαρυλο-5-υποκατεστημενων πυριδινων |
| PL2887924T3 (pl) | 2012-08-27 | 2017-09-29 | Cadila Healthcare Limited | Kompozycje farmaceutyczne etorykoksybu |
| ITVI20130014A1 (it) | 2013-01-22 | 2014-07-23 | Italiana Sint Spa | Procedimento molto efficiente per preparare un intermedio di etoricoxib |
| WO2014114352A1 (en) * | 2013-01-25 | 2014-07-31 | Synthon Bv | Process for making etoricoxib |
| CN104418799A (zh) * | 2013-09-03 | 2015-03-18 | 天津药物研究院 | 一种依托考昔的晶型及其制备方法和应用 |
| WO2015036550A1 (en) | 2013-09-13 | 2015-03-19 | Synthon B.V. | Process for making etoricoxib |
| EP3268085A4 (en) | 2015-03-13 | 2018-10-31 | The Board of Trustees of The Leland Stanford Junior University | Ltb4 inhibition to prevent and treat human lymphedema |
| CN104817473A (zh) * | 2015-03-27 | 2015-08-05 | 南京大学 | 1-二甲氨基-3-二甲亚胺基-2-氯丙烯高氯酸盐在制备依托考昔中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA988522A (en) * | 1972-05-05 | 1976-05-04 | Haydn W.R. Williams | 1,8-naphthyridine compounds |
| DE3842062A1 (de) * | 1988-12-14 | 1990-06-28 | Hoechst Ag | Explosionssichere 1-dimethylamino-3-dimethylimino-2-arylpropen-1-salze, verfahren zu ihrer herstellung und ihre verwendung |
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| IL127441A (en) * | 1996-07-18 | 2003-02-12 | Merck Frosst Canada Inc | Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors |
-
1999
- 1999-04-20 SK SK1589-2000A patent/SK284805B6/sk not_active IP Right Cessation
- 1999-04-20 IL IL13912799A patent/IL139127A0/xx active IP Right Grant
- 1999-04-20 KR KR10-2000-7011764A patent/KR100414998B1/ko active Protection Beyond IP Right Term
- 1999-04-20 AT AT99918706T patent/ATE272613T1/de active
- 1999-04-20 EA EA200001102A patent/EA002975B1/ru not_active IP Right Cessation
- 1999-04-20 RS YUP-641/00A patent/RS49945B/sr unknown
- 1999-04-20 EP EP99918706A patent/EP1071745B1/en not_active Expired - Lifetime
- 1999-04-20 DK DK99918706T patent/DK1071745T3/da active
- 1999-04-20 CZ CZ20003940A patent/CZ292515B6/cs not_active IP Right Cessation
- 1999-04-20 ES ES99918706T patent/ES2226378T3/es not_active Expired - Lifetime
- 1999-04-20 CN CNB998075507A patent/CN1178658C/zh not_active Expired - Lifetime
- 1999-04-20 DE DE69919151T patent/DE69919151T2/de not_active Expired - Lifetime
- 1999-04-20 HU HU0101407A patent/HU227627B1/hu unknown
- 1999-04-20 BR BRPI9909844-0A patent/BR9909844B1/pt not_active IP Right Cessation
- 1999-04-20 PT PT99918706T patent/PT1071745E/pt unknown
- 1999-04-20 SI SI9930632T patent/SI1071745T1/xx unknown
- 1999-04-20 JP JP2000545976A patent/JP3325264B2/ja not_active Expired - Lifetime
- 1999-04-20 WO PCT/US1999/008645 patent/WO1999055830A2/en active IP Right Grant
- 1999-04-20 UA UA2000116652A patent/UA57143C2/uk unknown
- 1999-04-20 BR BRPI9917739A patent/BRPI9917739B8/pt not_active IP Right Cessation
- 1999-04-20 PL PL344108A patent/PL193248B1/pl unknown
- 1999-04-20 NZ NZ507597A patent/NZ507597A/xx not_active IP Right Cessation
- 1999-04-20 CA CA002329193A patent/CA2329193C/en not_active Expired - Lifetime
- 1999-04-20 AU AU36557/99A patent/AU759469B2/en not_active Expired
- 1999-04-23 US US09/298,127 patent/US6040319A/en not_active Expired - Lifetime
- 1999-04-23 AR ARP990101884A patent/AR015279A1/es active IP Right Grant
- 1999-04-23 TW TW088106545A patent/TW474934B/zh active
-
2000
- 2000-01-21 US US09/488,774 patent/US6252116B1/en not_active Expired - Fee Related
- 2000-10-18 IL IL139127A patent/IL139127A/en not_active IP Right Cessation
- 2000-10-24 HR HR20000722A patent/HRP20000722B1/xx not_active IP Right Cessation
-
2001
- 2001-03-26 HK HK01102195A patent/HK1031399A1/xx not_active IP Right Cessation
-
2002
- 2002-05-22 JP JP2002147700A patent/JP3834263B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR015279A1 (es) | Proceso para la sintesis de inhibidores de cox-2 y compuestos intermediarios | |
| ATE145891T1 (de) | Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür | |
| ES531393A0 (es) | Procedimiento para la produccion de nuevos derivados de n-(2-nitrofenil)-4-aminopirimidina. | |
| EA199800388A1 (ru) | Производные фенилуксусной кислоты, способ и промежуточные продукты для их получения и содержащие их средства | |
| CO5140073A1 (es) | Derivados de 2,3,4,5-tetrahidro-1h-3-benzapina | |
| DE69615695D1 (de) | Verfahren zur herstellung von 1,4-benzodioxanderivaten. | |
| DK716188D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
| PE20050160A1 (es) | 3-aminopirrolidinas como inhibidores de la captacion de monoaminas | |
| ATE50772T1 (de) | Verfahren zur herstellung von erythrobishydroxyalkensa¨re-derivaten. | |
| DE69513657D1 (de) | Verfahren zur Herstellung von 1-substituierten 2-Cyanoimidazolen | |
| PT90912A (pt) | Processo para a preparacao de derivados de tiofenol | |
| ATE428693T1 (de) | Prostaglandinsynthese | |
| BR0212982A (pt) | Processo para preparar um composto, e, composto | |
| CO4810299A1 (es) | Procedimiento para alquilar sulfonamidas impedidas esteri- camente | |
| AR013183A1 (es) | Procedimiento para producir un compuesto derivado de indol, compuestos obtenidos e intermediarios | |
| AR038931A1 (es) | Proceso para la preparacion de piperazinas quirales 1,4-disustituidas | |
| RS49829B (sr) | Postupak i intermedijeri za proizvodnju piridin-2,3-dikarboksilat jedinjenja | |
| DK0945430T3 (da) | N-phenylacetoacetamider og fremgangsmåde til fremstilling deraf | |
| DK133285A (da) | Fremgangsmaade og udgangsmateriale til fremstilling af bestatinderivater | |
| EA200400876A1 (ru) | Способ получения производных толуола | |
| HUP0303686A2 (hu) | Eljárás Delta1-pirrolin-származékok előállítására és az új intermedierek | |
| ES8502699A1 (es) | Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas | |
| EA199900736A1 (ru) | Эффективный синтез 1,4-дигидро 2h-3,1-бензоксазин-2-она | |
| PE20030758A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion | |
| CO5150169A1 (es) | Sintesis de intermediarios utiles para pareparar compuestos triciclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |